PL2999701T3 - 2-fenyloimidazo[1,2-a]pirymidyny jako środki do obrazowania - Google Patents

2-fenyloimidazo[1,2-a]pirymidyny jako środki do obrazowania

Info

Publication number
PL2999701T3
PL2999701T3 PL14724757T PL14724757T PL2999701T3 PL 2999701 T3 PL2999701 T3 PL 2999701T3 PL 14724757 T PL14724757 T PL 14724757T PL 14724757 T PL14724757 T PL 14724757T PL 2999701 T3 PL2999701 T3 PL 2999701T3
Authority
PL
Poland
Prior art keywords
phenylimidazo
pyrimidines
imaging agents
imaging
agents
Prior art date
Application number
PL14724757T
Other languages
English (en)
Inventor
Luca Gobbi
Henner Knust
Matthias Koerner
Dieter Muri
Original Assignee
F. Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann-La Roche Ag filed Critical F. Hoffmann-La Roche Ag
Publication of PL2999701T3 publication Critical patent/PL2999701T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0459—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL14724757T 2013-05-23 2014-05-19 2-fenyloimidazo[1,2-a]pirymidyny jako środki do obrazowania PL2999701T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13168830 2013-05-23

Publications (1)

Publication Number Publication Date
PL2999701T3 true PL2999701T3 (pl) 2017-09-29

Family

ID=48446195

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14724757T PL2999701T3 (pl) 2013-05-23 2014-05-19 2-fenyloimidazo[1,2-a]pirymidyny jako środki do obrazowania

Country Status (20)

Country Link
US (1) US9801961B2 (pl)
EP (1) EP2999701B1 (pl)
JP (1) JP6130055B2 (pl)
KR (1) KR101770494B1 (pl)
CN (1) CN105229009B (pl)
AR (1) AR096371A1 (pl)
AU (1) AU2014270524B2 (pl)
BR (1) BR112015025140A2 (pl)
CA (1) CA2907605A1 (pl)
DK (1) DK2999701T3 (pl)
ES (1) ES2629389T3 (pl)
HU (1) HUE033612T2 (pl)
MX (1) MX2015015893A (pl)
PL (1) PL2999701T3 (pl)
RU (1) RU2665580C2 (pl)
SG (1) SG11201509503QA (pl)
SI (1) SI2999701T1 (pl)
TW (1) TW201500360A (pl)
WO (1) WO2014187762A1 (pl)
ZA (1) ZA201506570B (pl)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112017021408B1 (pt) 2015-04-08 2022-05-17 Bayer Cropscience Aktiengesellschaft Derivados de heterociclo bicíclico condensado, método para controlar pragas animais, e formulação agroquímica
CN108137548A (zh) 2015-08-07 2018-06-08 拜耳作物科学股份公司 作为农药的2-(杂)芳基取代的稠合杂环衍生物
BR112018006005A2 (pt) * 2015-09-29 2018-10-30 Oncotherapy Science Inc composto bicíclico e uso do mesmo para inibição de suv39h2
US10550116B2 (en) 2015-10-26 2020-02-04 Bayer Cropscience Aktiengesellschaft Fused bicyclic heterocycle derivatives as pesticides
WO2017093180A1 (de) 2015-12-01 2017-06-08 Bayer Cropscience Aktiengesellschaft Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
CN105582168A (zh) * 2016-01-08 2016-05-18 王明强 一种治疗体弱多病、元气不足、免疫力低下的中药药剂
WO2017144341A1 (de) 2016-02-23 2017-08-31 Bayer Cropscience Aktiengesellschaft Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
WO2017174414A1 (de) 2016-04-05 2017-10-12 Bayer Cropscience Aktiengesellschaft Naphthalin-derivate als schädlingsbekämpfungsmittel
EP3241830A1 (de) 2016-05-04 2017-11-08 Bayer CropScience Aktiengesellschaft Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
MX2019000793A (es) 2016-07-19 2019-06-20 Bayer Cropscience Ag Derivados de heterociclos biciclicos condensados como pesticidas.
IL264239B (en) 2016-07-22 2022-08-01 Ac Immune Sa Compounds for imaging tau protein aggregates
JP7059270B2 (ja) 2016-07-22 2022-04-25 エーシー・イミューン・エス・アー タウタンパク質凝集体を画像化するための化合物
EP3497102B1 (de) 2016-08-15 2022-12-07 Bayer CropScience Aktiengesellschaft Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
EP3515921B1 (de) 2016-09-19 2021-10-27 Bayer CropScience Aktiengesellschaft Pyrazolo[1,5-a]pyridin- derivative und ihre verwendung als schädlingsbekämpfungsmittel
WO2018065288A1 (de) 2016-10-07 2018-04-12 Bayer Cropscience Aktiengesellschaft 2-[2-phenyl-1-(sulfonylmethyl)vinyl]-imidazo[4,5-b]pyridin-derivate und verwandte verbindungen als schädlingsbekämpfungsmittel im pflanzenschutz
AU2018208422B2 (en) 2017-01-10 2021-11-11 Bayer Aktiengesellschaft Heterocyclene derivatives as pest control agents
UY37556A (es) 2017-01-10 2018-07-31 Bayer Ag Derivados heterocíclicos como pesticidas
WO2018138050A1 (de) 2017-01-26 2018-08-02 Bayer Aktiengesellschaft Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
US20200128830A1 (en) 2017-04-24 2020-04-30 Bayer Aktiengesellschaft Fused bicyclic heterocycle derivatives as pesticides
JP6831802B2 (ja) * 2018-01-12 2021-02-17 上海富吉医療器械有限公司Shanghai Chartwell Medical Instrument Co., Ltd. 放射性核種標識化合物及びこれを含有するイメージング剤
EP3305786A3 (de) 2018-01-22 2018-07-25 Bayer CropScience Aktiengesellschaft Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
EP3743426A1 (en) 2018-01-24 2020-12-02 AC Immune SA Azacarboline compounds for the detection of tau aggregates
EP3743423A1 (en) 2018-01-24 2020-12-02 AC Immune SA Gamma-carboline compounds for the detection of tau aggregates
CN111741958A (zh) 2018-02-21 2020-10-02 拜耳公司 作为害虫防治剂的稠合双环杂环衍生物
ES2988770T3 (es) * 2018-06-08 2024-11-21 Ac Immune Sa Nuevos compuestos para diagnóstico
CN113710669A (zh) 2019-02-26 2021-11-26 拜耳公司 作为农药的稠合双环杂环衍生物
JP7535532B2 (ja) 2019-02-26 2024-08-16 バイエル・アクチエンゲゼルシヤフト 有害生物防除剤としての縮合二環式複素環式誘導体
CN114890955A (zh) * 2022-06-23 2022-08-12 江西瑞威尔生物科技有限公司 一种n取代吗啉类有机化合物的制备工艺
CA3261365A1 (en) * 2022-07-28 2024-02-01 Ac Immune Sa NEW COMPOUNDS
AR134414A1 (es) * 2023-11-21 2026-01-14 Novartis Ag Imidazoarenos sustituidos y métodos para su uso

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2264403C2 (ru) * 1999-11-10 2005-11-20 Орто-Макнейл Фармасьютикал, Инк. Замещенные 2-арил-3-(гетероарил) имидазо [1,2-а] пиримидины, содержащие их фармацевтические композиции и связанные с ними способы
EP1294723A1 (en) * 2000-05-24 2003-03-26 MERCK SHARP & DOHME LTD. 3-phenyl-imidazo-pyrimidine derivatives as ligands for gaba receptors
US20070031328A1 (en) 2005-06-24 2007-02-08 Kung Hank F Radiolabeled-pegylation of ligands for use as imaging agents
WO2007033080A2 (en) 2005-09-12 2007-03-22 Emory University Alzheimer's disease imaging agents
WO2007034282A2 (en) * 2005-09-19 2007-03-29 Pfizer Products Inc. Diaryl-imidazole compounds condensed with a heterocycle as c3a receptor antagonists
EP1956013B1 (en) * 2005-11-30 2016-04-13 Fujifilm RI Pharma Co., Ltd. Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition
US7700616B2 (en) * 2006-05-08 2010-04-20 Molecular Neuroimaging, Llc. Compounds and amyloid probes thereof for therapeutic and imaging uses
RU2008150377A (ru) 2006-05-19 2010-06-27 Нихон Меди-Физикс Ко., Лтд. (Jp) Новое соединение, обладающее сродством к амилоиду
US8691187B2 (en) * 2009-03-23 2014-04-08 Eli Lilly And Company Imaging agents for detecting neurological disorders
US8410117B2 (en) * 2010-03-26 2013-04-02 Hoffmann-La Roche Inc. Imidazopyrimidine derivatives
JP6212628B2 (ja) * 2013-04-29 2017-10-11 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 2−フェニル又は2−ヘタリールイミダゾール[1,2−a]ピリジン誘導体

Also Published As

Publication number Publication date
TW201500360A (zh) 2015-01-01
KR20150144796A (ko) 2015-12-28
SG11201509503QA (en) 2015-12-30
RU2665580C2 (ru) 2018-08-31
US20170128598A1 (en) 2017-05-11
ES2629389T3 (es) 2017-08-09
CA2907605A1 (en) 2014-11-27
BR112015025140A2 (pt) 2017-07-18
KR101770494B1 (ko) 2017-08-22
JP2016520091A (ja) 2016-07-11
AU2014270524A8 (en) 2015-09-24
AR096371A1 (es) 2015-12-23
AU2014270524B2 (en) 2018-01-04
US9801961B2 (en) 2017-10-31
RU2015149528A3 (pl) 2018-03-22
RU2015149528A (ru) 2017-06-28
DK2999701T3 (en) 2017-07-10
WO2014187762A1 (en) 2014-11-27
EP2999701B1 (en) 2017-04-12
SI2999701T1 (sl) 2017-08-31
AU2014270524A1 (en) 2015-09-17
CN105229009A (zh) 2016-01-06
CN105229009B (zh) 2017-09-29
JP6130055B2 (ja) 2017-05-17
ZA201506570B (en) 2017-02-22
MX2015015893A (es) 2016-03-04
HK1213558A1 (zh) 2016-07-08
HUE033612T2 (en) 2017-12-28
EP2999701A1 (en) 2016-03-30

Similar Documents

Publication Publication Date Title
ZA201506570B (en) 2-phenylimidazo[1,2-a]pyrimidines as imaging agents
IL243092A0 (en) New triazolo[d–4,5]pyrimidine histories
IL234485A (en) Compounds based on imidazo [2,1 – b] pyridazine
IL246028A0 (en) Compounds 2 - amino - 6 - fluoro - n - [ - fluoro - pyridine - 3 yl] pyrazolo (1, 5 - a ) pyrimidine - 3 - carboxamide, their solid forms, preparations containing them and methods for their preparation
PT2794611T (pt) Pirazolo[1,5-a]pirimidinas como agentes antivirais
SI2963043T1 (sl) Derivat tetrahidroimidazo(1,5-d)(1,4)oksazepina
AP2015008867A0 (en) 3,4-dihydroisquinolin-2(1h)-yl compounds
EP3067356A4 (en) Pyrrolo pyrimidine derivative
ZA201406323B (en) Triazolo[4,5-d]pyrimidine derivatives
PL3129374T3 (pl) (5,6-Dihydro)pirymido[4,5-e]indolizyny
ZA201605666B (en) Pyrazolo[1,5-a]pyrimidines as antiviral compounds
IL242162B (en) Pyrrolo [2, 3 –d] pyrimidine derivatives as 2cb receptor agonists
ZA201507389B (en) 2-phenyl or 2-hetaryl imidazol[1,2-a]pyridine derivatives
ZA201507151B (en) Antiviral indolo[2,3-b]quinoxaline
EP3227292A4 (en) 4H-PYRIDO[1,2-a]PYRIMIDIN-4-ONE COMPOUNDS
HUE060733T2 (hu) Pirrolo[2,3-d]pirimidin vegyület vagy annak sója
HK1240222A1 (en) 4h-pyrido[1,2-a]pyrimidin-4-one compounds
GB201219129D0 (en) Triazolo(4,5-d)pyrmindine compounds
AU2014904868A0 (en) 4H-PYRIDO[1,2-a]PYRIMIDIN-4-ONE COMPOUNDS
GB201210863D0 (en) The footsie